Indian millionaire’s vaccine maker hunts for acquisitions

“I do see vaccine companies coming up on the block whether it could be in India or it could be abroad,” Adar Poonawalla, head of Serum Institute of India Pvt. Ltd., said in an interview in the company’s headquarters in Pune, India. “This is the lull before the storm. You are going to see either acquisitions or mergers.”

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at